Percutaneous penetration enhancers: Local versus transdermal activity

Pharmaceutical Science and Technology Today

Volumn 3, Issue 1, 2000, Pages 36-41

  Asbill, Charles S ^a   Michniak, Bozena B ^a  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 DECYLOXAZOLIDIN 2 ONE; BENZALKONIUM CHLORIDE; CETYLPYRIDINIUM SALT; DIMETICONE; ESSENTIAL OIL; EXCIPIENT; IMINOSULFURANE DERIVATIVE; LAUROCAPRAM; MACROGOL; MENTHOL; N 0131; N 0253; N 0539; N 0721; N 0915; NON PRESCRIPTION DRUG; OXAZOLIDINONE DERIVATIVE; PENETRATION ENHANCING AGENT; PESTICIDE; POLYMER; SUNSCREEN; TERPENE; THIOMENTHOL DERIVATIVE; UNCLASSIFIED DRUG;

DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG MECHANISM; DRUG RESEARCH; PERMEABILITY BARRIER; REVIEW; SKIN IRRITATION; SKIN PENETRATION; SKIN SURFACE; SKIN TOXICITY; STRATUM CORNEUM; STRUCTURE ACTIVITY RELATION;

EID: 0033979171     PISSN: 14615347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1461-5347(99)00225-4     Document Type: Review

References (43)

1. Schaefer H., Redelmeier T.E. Structure and dynamics of the skin barrier. Schaefer H., Redelmeier T.E. Skin Barrier. 1996;1-33 Karger, Tokyo, Japan.
2. Meier W., Hoppe U. Texture analysis of the surface of human skin. Skin Pharmacol. 8:1995;252-256.
3. Wertz P.W.et al. Covalently bound lipids of human stratum corneum. J. Invest. Dermatol. 92:1989;109-111.
4. Caputo R., Peluchette D. The junctions of normal human epidermis. A freeze-fracture study. J. Ultrastruct. Res. 61:1976;44-61.
5. Lavker R.M.et al. Morphology of aged skin. Lavker R.M. Dermatological Clinics: The Aging Skin. 1986;1-20 Saunders, Philadelphia, PA, USA.
6. Sandberg, L.B. et al. (1982) Structure of the elastic fiber: an overview. J. Invest. Dermatol. 79 (Suppl.) 1, 128s-132s.
7. Schaefer H.et al. Schaefer H. Skin Permeability. 1982;Springer, NY, USA.
8. Scheuplein R.J., Blank I.H. Permeability of the skin. Physiol. Rev. 51:1971;702-747.
9. Ghosh T.K.et al. Permeation enhancement. Ghosh T., Yum S., Pfister W. Transdermal and Topical Delivery Systems. 1997;21-22 Interpharm Press, Buffalo Grove, IL, USA.
10. Barry B.W. Lipid-protein-partitioning of skin penetration enhancement. J. Control. Release. 15:1991;237-248.
11. Ogiso T., Shintani M. Mechanism for the enhancement effect of fatty acids on the percutaneous absorption of propanolol. J. Pharm. Sci. 79:1990;1065-1076.
12. Zatz J.L. Zatz J.L. Skin Permeation Fundamentals and Applications. 1993;Allured Pub. Co, Carol Stream, IL, USA.
13. Williams A.C., Barry B.W. Skin absorption enhancers. Crit. Rev. Ther. Drug Carrier Syst. 9:1992;305-353.
14. Wester R.C., Maibach H.I. Penetration enhancement by skin hydration. Smith E.W., Maibach H.I. Percutaneous Penetration Enhancer. 1995;123-138 CRC Press, Boca Raton, FL, USA.
15. Shah V.P. Skin penetration enhancers: scientific perspective. Hsieh D.S. Drug Permeation and Enhancement. 1994;19-23 Marcel Dekker, New York, USA.
16. Pfister W.R., Hsieh D.S.T. Permeation enhancers compatible with transdermal drug delivery system. Part 1. Selection and formulation considerations. Pharm. Technol. 14(9):1990;132-140.
17. Pfister W.R., Hsieh D.S.T. Permeation enhancers compatible with transdermal drug delivery system. Part 2. System design considerations. Pharm. Technol. 14(10):1990;52-60.
18. Hori M.et al. Classification of percutaneous penetration enhancers. Bronaugh R.L., Maibach H.I. Percutaneous Absorption: Mechanisms, Methodology, Drug Delivery. 1989;197-211 Marcel Dekker, New York, USA.
19. Okamoto H.et al. Effect of 1-alkyl or 1-alkenylazacycloalkanone derivatives on the penetration of drugs with different lipophilicities. J. Pharm. Sci. 80:1991;39-45.
20. Barry B.W., Williams A.C. Terpenes as skin penetration enhancers. Walters K.A., Hadgraft J. Pharmaceutical Skin Penetration Enhancement. 1993;95-111 Marcel Dekker, New York, USA.
21. Takayama K.et al. O-alkyl and O-acylmenthol derivatives as potential skin penetration promoters. Proc. Intern. Symp. Control. Release Bioact. Mater. 22:1995;60-61.
22. Buyuktimkin, S. and Buyuktimkin, N. (1995) Physicochemical characteristics of some penetration enhancers and their effects on epithelial membrane lipid domains and the transdermal delivery of some drugs. Pharm. Res. (Suppl.), S285.
23. Michniak B.B.et al. In vitro evaluation of a series of Azone analogs as dermal penetration enhancers: IV amines. Int. J. Pharm. 116:1995;201-209.
24. Buyuktimkin N.et al. Transdermal drug permeation enhancement. Ghosh T., Yum S., Pfister W. Transdermal and Topical Drug Delivery Systems. 1997;357-475 Interpharm Press, Buffalo Grove, IL, USA.
25. Maibach H.et al. Epidermal enzymes as penetration enhancers in transdermal drug delivery. J. Pharm. Sci. 85:1996;249-262.
26. Hofland H.E. Estradiol permeation from nonionic surfactant vesicles through human stratum corneum. Pharm. Res. 11:1994;659-664.
27. Yokomizo Y. Effect of phospholipids on the percutaneous penetration of drugs through the dorsal skin of the guinea pig in vitro. Part 3. Effects of phospholipids on several drugs having different polarities. J. Control. Release. 42:1996;217-228.
28. Masson M.et al. Cyclodextrins as permeation enhancers: Some theoretical evaluations and in vitro testing. Int. J. Pharm. 59:1999;107-115.
29. Hadgraft J.et al. Mechanisms of action of skin penetration enhancers/retarders: Azone and analogues. Int. J. Pharm. 141:1996;17-25.
30. Aoyagi T.et al. Polymerization of benzalkonium chloride-type monomer and applications to percutaneous drug absorption enhancement. J. Control. Release. 13:1990;63-71.
31. Akitomoto T.et al. Polymeric percutaneous penetration enhancers synthesis and enhancing property of PEG/PDMS block copolymer with cationic end group. J. Control. Release. 49:1997;229-241.
32. Williams, A.C. and Barry, B.W. (1992) Skin absorption enhancers. Crit. Rev. Ther. Drug Carrier Sys. 9(3,4), 305-355.
33. Williams A.C., Barry B.W. Terpenes and the lipid protein partitioning theory of skin penetration enhancement. Pharm. Res. 8:1991;17-24.
34. Nagai T.et al. Thiomenthol derivatives as novel percutaneous absorption enhancers. Drug Dev. Ind. Pharm. 25:1999;89-102.
35. Rajadhyaksha V., Pfister W.R. Oxazolidinones. Drug Cosmet. Ind. 1. 36-47:1996;104-107.
36. Seth B. Transdermal delivery using decyloxazolidin-2-one. Arzneim.-Forsch. Drug Res. 42:1999;120-122.
37. Sharma A.et al. Dimethylsulfoxide-trifluoroacetic anhydride. A new and efficient agent for the preparation of iminosulfuranes. J. Org. Chem. 40:1975;2758-2764.
38. Michniak B.et al. In vitro evaluation of a series of Azone analogs as dermal penetraton enhancers. Part 2. (Thioimides). Int. J. Pharm. 94:1993;203-210.
39. Michniak B., Phillips C. Topical application of Azone analogs to hairless mouse skin: histopathological study. Int. J. Pharm. 125:1995;63-71.
40. Kim N.et al. Percutaneous penetration enhancement of aromatic s,s-dimethyliminosulfurane. Int. J. Pharm. 1999;. in press.
41. Barry B.W. Mode of action of penetration enhancers in human skin. J. Control. Release. 6:1987;85-97.
42. Lewis D., Hadgraft J. Mixed monolayers of dipalmitoyl phosphatidylcholine with Azone or oleic acid at the air-water interface. Int. J. Pharm. 65:1990;211-218.
43. Hoogstraate A.J.et al. Kinetics, ultrastructural aspects and molecular modeling of transdermal peptide flux enhancement by N-alkylazacycloheptanones. Int. J. Pharm. 76:1991;37-47.